Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.110
-0.090 (-4.09%)
Nov 21, 2024, 3:46 PM EST - Market closed

Edesa Biotech Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 2018 - 2017
Market Capitalization
71314987847
Upgrade
Market Cap Growth
-17.55%-6.42%-85.44%26.16%65.89%-
Upgrade
Enterprise Value
571907540
Upgrade
Last Close Price
2.204.426.4551.6656.4943.60
Upgrade
Forward PE
--56.67---
Upgrade
PS Ratio
----235.84113.77
Upgrade
PB Ratio
2.491.891.527.498.518.89
Upgrade
P/TBV Ratio
18.042.742.009.1618.708.89
Upgrade
EV/Sales Ratio
----226.7098.28
Upgrade
Debt / Equity Ratio
0.010.010.000.010.02-
Upgrade
Asset Turnover
----0.04-
Upgrade
Quick Ratio
1.103.293.907.644.7711.37
Upgrade
Current Ratio
1.293.534.258.295.3012.23
Upgrade
Return on Equity (ROE)
-129.29%-101.88%-156.34%-120.39%-88.61%-
Upgrade
Return on Assets (ROA)
-71.52%-56.33%-87.78%-116.79%-48.55%-
Upgrade
Return on Capital (ROIC)
-96.35%-69.64%-101.75%-131.97%-55.07%-
Upgrade
Earnings Yield
-96.98%-62.82%-123.19%-13.64%-8.21%-6.72%
Upgrade
FCF Yield
-75.46%-49.78%-86.24%-13.97%-6.44%-11.20%
Upgrade
Buyback Yield / Dilution
-17.51%-36.37%-21.50%-40.32%-87.63%-41.59%
Upgrade
Total Shareholder Return
-17.51%-36.37%-21.50%-40.32%-87.63%-41.59%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.